Skip to main content

Better Therapeutics, Inc.

BTTXDelisted May 16, 2024
Industry
Services-Health Services
SEC CIK
0001832415

Better Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Feb 13, 2024; 22 institutions reported holding it in 13F filings for Q4 2023, worth $281.2K in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Better Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

BTTX is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
22
+4 vs. Q3 2023
Shares held
1.47M
−1.06M (−41.9%) vs. Q3 2023
Total value
$281.2K
−$649.9K (−69.8%) vs. Q3 2023
New holders
6
6 more added
Sold out
2
5 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BTTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 22 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 20 institutionsQ1 2022: 14 institutionsQ2 2022: 14 institutionsQ3 2022: 16 institutionsQ4 2022: 17 institutionsQ1 2023: 15 institutionsQ2 2023: 15 institutionsQ3 2023: 18 institutionsQ4 2023: 22 institutionsQ1 2024: 3 institutionsQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2023: $281.2K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $16.4MQ1 2022: $7.16MQ2 2022: $2.77MQ3 2022: $3.11MQ4 2022: $1.75MQ1 2023: $1.04MQ2 2023: $1.17MQ3 2023: $931.1KQ4 2023: $281.2KQ1 2024: $1.45KQ2 2024: $37Q3 2024: $0Q4 2024: $0Q1 2025: $1Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BTTX and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$1
Q4 20241$0
Q3 20241$0
Q2 20241$37
Q1 20243$1.45K
Q4 202322$281.2K
Q3 202318$931.1K
Q2 202315$1.17M
Q1 202315$1.04M
Q4 202217$1.75M
Q3 202216$3.11M
Q2 202214$2.77M
Q1 202214$7.16M
Q4 202120$16.4M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Better Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding BTTX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada584$00.00%+390+201.0%Added
PSI Advisors, LLC65$130.00%00.0%Unchanged
Wells Fargo & Company179$350.00%+58+47.9%Added
Aspire Private Capital, LLC200$390.00%00.0%Unchanged
Bank of America Corp216$420.00%+216New
Jane Street Group, LLC10,336$2.02K0.00%+10,336New
Group One Trading, L.P.10,351$2.02K0.00%−8,347−44.6%Reduced
XTX Topco Ltd14,472$2.82K0.00%+14,472New
Ameriprise Financial Inc15,000$2.92K0.00%00.0%Unchanged
Northern Trust Corp16,703$3.26K0.00%00.0%Unchanged
HRT Financial LP25,312$4.00K0.00%+25,312New
Tower Research Capital LLC (TRC)22,443$4.38K0.00%−425−1.9%Reduced
CI Private Wealth, LLC29,180$5.69K0.00%+29,180New
Susquehanna International Group, LLP38,057$7.42K0.00%+38,057New
State Street Corp58,600$11.4K0.00%00.0%Unchanged
Capital Investment Advisory Services, LLC71,000$13.8K0.00%+30,000+73.2%Added
BlackRock Inc.88,635$17.3K0.00%−390−0.4%Reduced
Millennium Management LLC128,749$25.1K0.00%+91,876+249.2%Added
Geode Capital Management, LLC168,821$32.9K0.00%+61,943+58.0%Added
Vanguard Group Inc198,154$38.6K0.00%−301,743−60.4%Reduced
Citadel Advisors LLC216,165$42.2K0.00%+189,999+726.1%Added
MMCAP International Inc. SPC356,270$65.2K0.01%−1,226,809−77.5%Reduced
NWF Advisory Services Inc.0$00.00%−15,460−100.0%Sold out
JPMorgan Chase & Co0$00.00%−13−100.0%Sold out